Hi Dew, Can we get a new survey? Worst biotech exec of 2008..
II would suggest Kelly Martin from Elan on the list for his ashamedly pre-promtion of bapineuzimab prior to negative results. Thus, the preciptious drop from $37 to single digits. The people on the IV board are also creating revisionist history by blaming the share price on the credit markets. However, the stock dropped to single digists prior to market meltdown.